These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 39300412)

  • 1. Targeting cellular plasticity: esculetin-driven reversion of stem cell-like characteristics and EMT phenotype in transforming cells with sequential p53/p73 knockdowns.
    Mathur A; Bareja C; Mittal M; Singh A; Saluja D
    BMC Cancer; 2024 Sep; 24(1):1164. PubMed ID: 39300412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer.
    Sinha N; Meher BR; Naik PP; Panda PK; Mukhapadhyay S; Maiti TK; Bhutia SK
    Phytomedicine; 2019 Mar; 55():179-190. PubMed ID: 30668428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
    Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
    Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esculetin releases maturation arrest and induces terminal differentiation in leukemic blast cells by altering the Wnt signaling axes.
    Mathur A; Gangwar A; Saluja D
    BMC Cancer; 2023 May; 23(1):387. PubMed ID: 37127581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
    Ning X; Wang C; Zhang M; Wang K
    Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells.
    Cai BH; Wu PH; Chou CK; Huang HC; Chao CC; Chung HY; Lee HY; Chen JY; Kannagi R
    Sci Rep; 2019 Jan; 9(1):950. PubMed ID: 30700826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
    Dang H; Ding W; Emerson D; Rountree CB
    BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Role of p73 in Cancer Microenvironment and DNA Damage Response.
    Rozenberg JM; Zvereva S; Dalina A; Blatov I; Zubarev I; Luppov D; Bessmertnyi A; Romanishin A; Alsoulaiman L; Kumeiko V; Kagansky A; Melino G; Barlev NA
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
    Naveen CR; Gaikwad S; Agrawal-Rajput R
    Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.
    Navas T; Kinders RJ; Lawrence SM; Ferry-Galow KV; Borgel S; Hollingshead MG; Srivastava AK; Alcoser SY; Makhlouf HR; Chuaqui R; Wilsker DF; Konaté MM; Miller SB; Voth AR; Chen L; Vilimas T; Subramanian J; Rubinstein L; Kummar S; Chen AP; Bottaro DP; Doroshow JH; Parchment RE
    Cancer Res; 2020 Jan; 80(2):304-318. PubMed ID: 31732654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells.
    Han XY; Wei B; Fang JF; Zhang S; Zhang FC; Zhang HB; Lan TY; Lu HQ; Wei HB
    PLoS One; 2013; 8(9):e73341. PubMed ID: 24039918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
    Chang CJ; Chao CH; Xia W; Yang JY; Xiong Y; Li CW; Yu WH; Rehman SK; Hsu JL; Lee HH; Liu M; Chen CT; Yu D; Hung MC
    Nat Cell Biol; 2011 Mar; 13(3):317-23. PubMed ID: 21336307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
    Li Y; Wang L; Pappan L; Galliher-Beckley A; Shi J
    Mol Cancer; 2012 Nov; 11():87. PubMed ID: 23174018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic roles of EMT-inducing transcription factors.
    Puisieux A; Brabletz T; Caramel J
    Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis.
    Zhang Y; Xu L; Wang P; Jian H; Shi X; Jia M; Mo L; Hu Z; Li H; Li J
    Cell Cycle; 2019 Aug; 18(16):1938-1947. PubMed ID: 31234753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells.
    Rana S; Gupta K; Gomez J; Matsuyama S; Chakrabarti A; Agarwal ML; Agarwal A; Agarwal MK; Wald DN
    FASEB J; 2010 Jun; 24(6):2126-34. PubMed ID: 20133503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer.
    Sacchetti A; Teeuwssen M; Verhagen M; Joosten R; Xu T; Stabile R; van der Steen B; Watson MM; Gusinac A; Kim WK; Ubink I; Van de Werken HJ; Fumagalli A; Paauwe M; Van Rheenen J; Sansom OJ; Kranenburg O; Fodde R
    Elife; 2021 May; 10():. PubMed ID: 34036938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.